Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Single-pass membrane and coiled-coil domain-containing protein 4 (SMCO4) is a human protein encoded by the SMCO4 gene (also known as C11orf75 or FN5), located on chromosome 11q13.3–q23.3[1][2][9][10]. SMCO4 is predicted to be a single-pass transmembrane protein with a coiled-coil domain and is present in the outer membrane of mitochondria[1][10]. Its structural features suggest it consists mainly of alpha-helices, with no known beta-turns or repeat elements[1]. The protein may be involved in processes related to protein–protein interaction, inferred from the presence of coiled-coil domains[6], and has predicted—though not experimentally confirmed—interactions with proteins such as BNIP3L, SYNE4, and CCDC155[1]. Expression is observed in numerous tissues with the highest levels in the salivary glands[1][8]. There is currently little direct evidence linking SMCO4 to therapeutic targeting, known drug interactions, biomarker status, or clear mechanisms relevant to human disease, and its molecular function remains largely uncharacterized[1][4][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Single-pass membrane and coiled-coil domain-containing protein 4 (SMCO4).